Skip to main content
Premium Trial:

Request an Annual Quote

BioWisdom to Incorporate InPharmix Medline Search Tool

NEW YORK, May 8 – Genomics information provider BioWisdom said Tuesday it would incorporate InPharmix’ Statistical Analysis of Text software for searching Medline data in Discovery Portfolio, an online service that searches public and proprietary data and delivers information based on customers’ targets of interest.

InPharmix’s STAT tool searches the Medline literature database of more than 10 million abstracts using a user-supplied query and then analyzes and scoring the findings.

“Medline is an incredibly useful resource, but sometimes finding the most relevant references within it can be a daunting task. InPharmix’s STAT tool helps manage this complexity,” Derek Jones, commercial director of BioWisdom, said in a statement.

Although this deal is non-financial, James Sluka, chief scientist at InPharmix of Greenwood, Ind., said he hoped that it would lead to further cooperation between his company and BioWisdom.

BioWisdom of Cambridge, UK, aggregates and aligns multidisciplinary data, information, and technology from both the public domain and from their proprietary partners. Users can view meta-data in order to help them make decisions about what data to license or purchase.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.